Personal Day Doing The Work Daily Exfoliating Treatment Liquid
FDA Label NDC 84234-002

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Personal Day Inc. for the product Personal Day Doing The Work Daily Exfoliating Treatment (NDC 84234-002). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding drug facts, active ingredients, purpose, uses, warnings, when using this product, keep out of reach of children., directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Drug Facts

Active Ingredients

Salicylic Acid 2%

Purpose

Acne treatment

Uses

  • Treats acne
  • Helps prevent the development of new acne blemishes

Warnings

For external use only

When Using This Product

skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

Keep Out Of Reach Of Children.

If swallowed, get medical help or contact a Poison Control Center immediately.

Directions

  • After cleansing, cover the affected area with a thin layer one to two times per week.
  • Because excessive drying of the skin may occur, start with one application (every other day), then gradually increase to daily use, if needed or as directed by a doctor. 
  • If bothersome dryness or peeling occurs, reduce application to every other day.

Inactive Ingredients

Water, Methylpropanediol, Glycerin, Niacinamide, Potassium Azeloyl Diglycinate, Lactic Acid, Sodium Hydroxide, Hydroxyacetophenone, Zinc Hydrolyzed Hyaluronate, 1,2-Hexanediol, Caprylyl Glycol, Xanthan Gum, Malic Acid, Sodium Gluconate, Biosaccharide Gum-4

Questions Or Comments?

1-888-404-3461

* Please review the disclaimer below.